Long non-coding RNAs LOC285194, RP11-462C24.1 and Nbla12061 in serum provide a new approach for distinguishing patients with colorectal cancer from healthy controls

Oncotarget

Volumn 7, Issue 43, 2016, Pages 70769-70778

  Wang, Chuanxi ^a   Yu, Jinyu ^a   Han, Yuping ^a   Li, Leping ^a   Li, Jie ^a   Li, Tao ^a   Qi, Peng ^b,c  

^a SHANDONG UNIVERSITY   (China)

^b FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

Biomarker; Colorectal cancer; Long non coding RNA; Serum

Indexed keywords

CA 125 ANTIGEN; CA 19-9 ANTIGEN; CA 724 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; LONG UNTRANSLATED RNA; TUMOR ANTIGEN; TUMOR MARKER; UNCLASSIFIED DRUG; LOC285194 LNCRNA, HUMAN;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CANCER DIAGNOSIS; CANCER SURGERY; COLORECTAL CANCER; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MOLECULAR DIAGNOSIS; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA BLOOD LEVEL; BIOLOGICAL MODEL; BLOOD; COLORECTAL TUMOR; COMPARATIVE STUDY; EARLY CANCER DIAGNOSIS; ISOLATION AND PURIFICATION; METABOLISM; MIDDLE AGED; PATHOLOGY; PROCEDURES; SEROLOGY; UPREGULATION;

BIOMARKERS, TUMOR; CA-125 ANTIGEN; CA-19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, LONG NONCODING; ROC CURVE; SEROLOGIC TESTS; UP-REGULATION;

EID: 84994285888     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.12220     Document Type: Article

References (33)

1. Jemal A, Bray F, Center M, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011; 61: 69-90. doi:
2. Bukowski J, Gozdz S, Sluszniak J, Korejba W, Zielinski A. [CA 19-9 and CA 125 antigens in the sera of patients with cancer of the large intestine in relation to its clinical progress]. Wiad Lek. 1989; 42: 30-4. doi:
3. Jain P, Mondal SK, Sinha SK, Mukhopadhyay M, Chakraborty I. Diagnostic and prognostic significance of different mucin expression, preoperative CEA, and CA-125 in colorectal carcinoma: A clinicopathological study. J Nat Sci Biol Med. 2014; 5: 404-8. doi: 10.4103/0976-9668.136207.
4. Toiyama Y, Tanaka K, Inoue Y, Mohri Y, Kusunoki M. Circulating cell-free microRNAs as biomarkers for colorectal cancer. Surg Today. 2016; 46: 13-24. doi: 10.1007/s00595-015-1138-y.
5. Hur K. MicroRNAs: promising biomarkers for diagnosis and therapeutic targets in human colorectal cancer metastasis. BMB Rep. 2015; 48: 217-22. doi:
6. Umemura T, Kuroki C. [Circulating MicroRNAs as Biomarkers of Colorectal Cancer]. Rinsho Byori. 2015; 63: 336-46. doi:
7. Mercer TR, Dinger ME, Mattick JS. Long non-coding RNAs: insights into functions. Nat Rev Genet. 2009; 10: 155-9. doi: 10.1038/nrg2521.
8. Ponting CP, Oliver PL, Reik W. Evolution and functions of long noncoding RNAs. Cell. 2009; 136: 629-41. doi: 10.1016/j.cell.2009.02.006.
9. Kohls K, Schmidt D, Holdenrieder S, Muller SC, Ellinger J. [Detection of cell-free lncRNA in serum of cancer patients]. Urologe A. 2015; 54: 819-25. doi: 10.1007/s00120-014-3655-5.
10. Bechtold ML, Ashraf I, Nguyen DL. A clinician's guide to fecal occult blood testing for colorectal cancer. South Med J. 2016; 109: 248-55. doi:
11. Kamel MM, Matboli M, Sallam M, Montasser IF, Saad AS, El-Tawdi AH. Investigation of long noncoding RNAs expression profile as potential serum biomarkers in patients with hepatocellular carcinoma. Transl Res. 2016; 168: 134-45 doi: 10.1016/j.trsl.2015.10.002.
12. Tong YS, Wang XW, Zhou XL, Liu ZH, Yang TX, Shi WH, Xie HW, Lv J, Wu QQ, Cao XF. Identification of the long non-coding RNA POU3F3 in plasma as a novel biomarker for diagnosis of esophageal squamous cell carcinoma. Mol Cancer. 2015; 14: 3. doi: 10.1186/1476-4598-14-3.
13. Xie H, Ma H, Zhou D. Plasma HULC as a promising novel biomarker for the detection of hepatocellular carcinoma. Biomed Res Int. 2013; 2013: 136106. doi: 10.1155/2013/136106.
14. Tang J, Jiang R, Deng L, Zhang X, Wang K, Sun B. Circulation long non-coding RNAs act as biomarkers for predicting tumorigenesis and metastasis in hepatocellular carcinoma. Oncotarget. 2015; 6: 4505-15. doi: 10.18632/oncotarget.2934.
15. Rabeneck L, Horton S, Zauber AG, Earle C. (2015). Colorectal cancer. In: Gelband H, Jha P, Sankaranarayanan R, Horton S, eds. Cancer: disease control priorities. (Washington, DC: World Bank), pp. 101-20.
16. Ling H, Spizzo R, Atlasi Y, Nicoloso M, Shimizu M, Redis RS, Nishida N, Gafa R, Song J, Guo Z, Ivan C, Barbarotto E, De Vries I, et al. CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer. Genome Res. 2013; 23: 1446-61. doi: 10.1101/gr.152942.112.
17. Qi P, Xu MD, Ni SJ, Shen XH, Wei P, Huang D, Tan C, Sheng WQ, Zhou XY, Du X. Down-regulation of ncRAN, a long non-coding RNA, contributes to colorectal cancer cell migration and invasion and predicts poor overall survival for colorectal cancer patients. Mol Carcinog. 2015; 54: 742-50 doi: 10.1002/mc.22137.
18. Zhai H, Fesler A, Schee K, Fodstad O, Flatmark K, Ju J. Clinical significance of long intergenic noncoding RNAp21 in colorectal cancer. Clin Colorectal Cancer. 2013; 12: 261-6. doi: 10.1016/j.clcc.2013.06.003.
19. Zhang W, Ren SC, Shi XL, Liu YW, Zhu YS, Jing TL, Wang FB, Chen R, Xu CL, Wang HQ, Wang HF, Wang Y, Liu B, et al. A novel urinary long non-coding RNA transcript improves diagnostic accuracy in patients undergoing prostate biopsy. Prostate. 2015; 75: 653-61. doi: 10.1002/pros.22949.
20. Liu Z, Shao Y, Tan L, Shi H, Chen S, Guo J. Clinical significance of the low expression of FER1L4 in gastric cancer patients. Tumour Biol. 2014; 35: 9613-7. doi: 10.1007/s13277-014-2259-4.
21. Shao Y, Ye M, Jiang X, Sun W, Ding X, Liu Z, Ye G, Zhang X, Xiao B, Guo J. Gastric juice long noncoding RNA used as a tumor marker for screening gastric cancer. Cancer. 2014; 120: 3320-8. doi: 10.1002/cncr.28882.
22. Giraldez MD, Lozano JJ, Ramirez G, Hijona E, Bujanda L, Castells A, Gironella M. Circulating microRNAs as biomarkers of colorectal cancer: results from a genome-wide profiling and validation study. Clin Gastroenterol Hepatol. 2013; 11: 681-8 e3. doi: 10.1016/j.cgh.2012.12.009.
23. Qi P, Xu MD, Ni SJ, Huang D, Wei P, Tan C, Zhou XY, Du X. Low expression of LOC285194 is associated with poor prognosis in colorectal cancer. J Transl Med. 2013; 11: 122. doi: 10.1186/1479-5876-11-122.
24. Liu Q, Huang J, Zhou N, Zhang Z, Zhang A, Lu Z, Wu F, Mo YY. LncRNA loc285194 is a p53-regulated tumor suppressor. Nucleic Acids Res. 2013; 41: 4976-87. doi: 10.1093/nar/gkt182.
25. Tong YS, Zhou XL, Wang XW, Wu QQ, Yang TX, Lv J, Yang JS, Zhu B, Cao XF. Association of decreased expression of long non-coding RNA LOC285194 with chemoradiotherapy resistance and poor prognosis in esophageal squamous cell carcinoma. J Transl Med. 2014; 12: 233. doi: 10.1186/s12967-014-0233-y.
26. Ding YC, Yu W, Ma C, Wang Q, Huang CS, Huang T. Expression of long non-coding RNA LOC285194 and its prognostic significance in human pancreatic ductal adenocarcinoma. Int J Clin Exp Pathol. 2014; 7: 8065-70. doi:
27. Pasic I, Shlien A, Durbin AD, Stavropoulos DJ, Baskin B, Ray PN, Novokmet A, Malkin D. Recurrent focal copynumber changes and loss of heterozygosity implicate two noncoding RNAs and one tumor suppressor gene at chromosome 3q13.31 in osteosarcoma. Cancer Res. 2010; 70: 160-71. doi: 10.1158/0008-5472.can-09-1902.
28. Dong L, Qi P, Xu MD, Ni SJ, Huang D, Xu QH, Weng WW, Tan C, Sheng WQ, Zhou XY, Du X. Circulating CUDR, LSINCT-5 and PTENP1 long noncoding RNAs in sera distinguish patients with gastric cancer from healthy controls. Int J Cancer. 2015; 137: 1128-35. doi: 10.1002/ijc.29484.
29. Yu M, Ohira M, Li Y, Niizuma H, Oo ML, Zhu Y, Ozaki T, Isogai E, Nakamura Y, Koda T, Oba S, Yu B, Nakagawara A. High expression of ncRAN, a novel non-coding RNA mapped to chromosome 17q25.1, is associated with poor prognosis in neuroblastoma. Int J Oncol. 2009; 34: 931-8. doi:
30. Shi D, Zheng H, Zhuo C, Peng J, Li D, Xu Y, Li X, Cai G, Cai S. Low expression of novel lncRNA RP11-462C24.1 suggests a biomarker of poor prognosis in colorectal cancer. Med Oncol. 2014; 31: 31. doi: 10.1007/s12032-014-0031-7.
31. Li Q, Shao Y, Zhang X, Zheng T, Miao M, Qin L, Wang B, Ye G, Xiao B, Guo J. Plasma long noncoding RNA protected by exosomes as a potential stable biomarker for gastric cancer. Tumour Biol. 2015; 36: 2007-12. doi: 10.1007/s13277-014-2807-y.
32. Kogure T, Yan IK, Lin WL, Patel T. Extracellular Vesicle-Mediated Transfer of a Novel Long Noncoding RNA TUC339: A Mechanism of Intercellular Signaling in Human Hepatocellular Cancer. Genes Cancer. 2013; 4: 261-72. doi: 10.1177/1947601913499020.
33. Quesenberry PJ, Goldberg LR, Aliotta JM, Dooner MS, Pereira MG, Wen S, Camussi G. Cellular phenotype and extracellular vesicles: basic and clinical considerations. Stem Cells Dev. 2014; 23: 1429-36. doi: 10.1089/scd.2013.0594.